Form 4: Astrana Health CEO Exercises Options, Boosts Stake

Astrana Health's CEO and President, Brandon Sim, acquired 21,334 shares of common stock through option exercise on February 2, 2026.

Summary

• Brandon Sim, CEO and President of Astrana Health, Inc. (ASTH), acquired 21,334 shares of common stock.
• The acquisition occurred on February 2, 2026, through the exercise of fully vested stock options at a price of $23.24 per share.
• Following this transaction, Sim's direct beneficial ownership stands at 1,045,329 shares.
• This direct ownership includes 29,919 unvested restricted shares vesting on June 27, 2026, and 51,309 unvested restricted shares vesting in three equal semi-annual installments beginning March 31, 2026.
• It also includes 75,433 restricted stock units (RSUs) vesting in five equal semi-annual installments beginning April 2, 2026, and 127,437 RSUs vesting in seven equal semi-annual installments beginning March 5, 2026.
• Additionally, 1,420 shares were acquired under the Issuer's Employee Stock Purchase Plan.
• Sim also holds indirect beneficial ownership of 258,824 shares through the Sim Family Irrevocable Trust 2021 and 392,816 shares through the Brandon Sim 2020 Irrevocable Trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a CEO increasing their direct stake through option exercise typically indicates confidence in the company's future prospects, although it's a routine compensation event.

Positives

• CEO Brandon Sim increased his direct ownership in Astrana Health by exercising stock options, signaling confidence in the company's future.
• The exercise price of $23.24 per share indicates a specific valuation at the time of the option grant or exercise.

Future Outlook

The filing details future vesting schedules for restricted stock and restricted stock units, indicating ongoing equity incentives tied to continuous employment with Astrana Health, Inc.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by a CEO, are often viewed by the market as a positive signal, suggesting management's confidence in the company's future performance and strategic direction. This transaction aligns with typical executive compensation structures involving equity incentives.

Comparison to Industry Standards

• StockSavvy.ai observes that the exercise of vested stock options by a CEO is a common practice in publicly traded companies across various sectors, including healthcare services. While specific comparable companies or projects are not detailed in this filing, such transactions are standard mechanisms for executives to realize value from their equity compensation and increase their direct stake. For instance, similar option exercises are frequently seen at healthcare providers like UnitedHealth Group (UNH) or Humana (HUM) when their executives convert vested options into common stock.

Related Party Transactions

• Indirect beneficial ownership of 258,824 shares held by the Sim Family Irrevocable Trust 2021.
• Indirect beneficial ownership of 392,816 shares held by the Brandon Sim 2020 Irrevocable Trust.

Stakeholder Impact

• Shareholders: Increased insider ownership may be perceived positively, signaling alignment of interests between management and shareholders.
• Employees: The detailed vesting schedules for restricted stock and RSUs highlight ongoing equity incentives as part of employee compensation.

Next Steps

• Vesting of 29,919 restricted shares on June 27, 2026.
• Vesting of 51,309 restricted shares in three equal semi-annual installments, beginning March 31, 2026.
• Vesting of 75,433 restricted stock units in five equal semi-annual installments, beginning April 2, 2026.
• Vesting of 127,437 restricted stock units in seven equal semi-annual installments, beginning March 5, 2026.

Key Dates

Recommendation

While the CEO's exercise of stock options and increased direct ownership is a positive signal of confidence, this single transaction, a routine part of executive compensation, does not provide sufficient fundamental or strategic information to alter a broader investment thesis. Investors should hold and monitor further company developments and financial performance.

Keywords

Astrana Health, ASTH, Brandon Sim, CEO, Insider Transaction, Form 4, Stock Option Exercise, Beneficial Ownership, Restricted Stock Units, Employee Stock Purchase Plan